US Patent Issued to Mayne Pharma on July 8 for "Stabilized oxymetazoline formulations and their uses" (California, Massachusetts Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,255, issued on July 8, was assigned to Mayne Pharma LLC (Raleigh, N.C.).

"Stabilized oxymetazoline formulations and their uses" was invented by Pramod Sarpotdar (Rohnert Park, Calif.), Kevin Warner (Anaheim, Calif.), Steven Zhang (Newton, Mass.), Gurpreet Ahluwalia (Tustin, Calif.) and Amy Kuang (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the sit...